-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver disease (NAFLD), rather than hepatitis C or hepatitis B, is currently the most common liver disease among people living with HIV (PLWH)
.
The characteristic of NAFLD is that in the absence of a high-fat diet, the proportion of fatty degeneration in liver cells is greater than 5%
.
Non-alcoholic fatty liver disease (NAFLD), rather than hepatitis C or hepatitis B, is currently the most common liver disease among people living with HIV (PLWH)
In this cross-sectional study, transient elastography for liver testing was performed in PLWH without heavy drinking and hepatitis B and C virus infection
.
Diagnostic consensus
Among the 361 PLWH included, the prevalence of NAFLD and MAFLD were 37.
67% and 34.
90%, respectively
.
Compared with the non-MAFLD group, the level of alanine aminotransferase (ALT) in the MAFLD group was increased (44.
44% vs 16.
cholesterol
Figure: Display of metabolic-related fatty liver risk factors in HIV-infected patients
This study confirmed that one third of HIV-infected patients have MAFLD, which is highly consistent with the prevalence of NAFLD
.
Therefore, clinicians need to conduct routine screening for MAFLD in HIV-infected patients to improve the prognosis of these patients
.
This study confirmed that one third of HIV-infected patients have MAFLD, which is highly consistent with the prevalence of NAFLD
Original source:
Danping Liu.
Et al.
Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Leave a message here